论文部分内容阅读
本文报道日本36所临床单位1975～1979年间2,166例无排卵性不孕症的日本妇女接受6096个hMG-hCG治疗周期的结果.对排卵率、妊娠率、卵巢过度刺激综合征(OHSS)、多胎妊娠发生率、流产率、新生儿畸形率与西方国家报道的资料比较研究有无种族差异.在这组不孕妇女中血清FSH值正常或降低,Ⅱ度闭经者1,007例(46.5%),Ⅰ度闭经者654例(30.2%),无排卵者235例(10.8%),无排卵性月经稀发者270例(12.5%).根据不同病人在不同治疗周期中卵巢反应,调节hMG剂量和用药时间(Humegon含FSH75IU),hMG的日用量
This article reports the results of 6096 hMG-hCG treatment cycles in 2,166 Japanese women with anovulatory infertility in 36 Japanese clinical units between 1975 and 1979. The results of ovulation rate, pregnancy rate, ovarian hyperstimulation syndrome (OHSS), multiple births Pregnancy rate, miscarriage rate, neonatal deformity rate compared with the data reported in Western countries, there is no racial differences in this group of infertile women with normal or decreased serum FSH value, 1,007 cases (Ⅱ) amenorrhea (46.5%), Ⅰ There were 654 cases (30.2%) with amenorrhea, 235 cases (10.8%) with anovulation, 270 cases (12.5%) with anovulatory menstruation.On the basis of ovarian response of different patients in different treatment cycles, the dosage and dosage of hMG Time (Humegon with FSH75IU), hMG daily consumption